Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 4.325.238.608.177.07

What is the latest Working Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Working Capital/Sales ratio of PIRAMAL PHARMA is 4.32 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20264.32
Mar20255.23
Mar20248.60
Mar20238.17
Mar20227.07

How is Working Capital/Sales of PIRAMAL PHARMA Trending?

Years Working Capital/Sales % Change
Mar2026 4.32
-17.40
Mar2025 5.23
-39.19
Mar2024 8.6
5.26
Mar2023 8.17
15.56
Mar2022 7.07 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Working Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹27,977.3 Cr 5.5% -0.9% 2.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,437.0 Cr 1.8% -1.7% 14.6% Stock Analytics
DIVIS LABORATORIES ₹248,054.0 Cr 2.6% 9.8% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,842.0 Cr 2.4% -0.5% 36% Stock Analytics
CIPLA ₹111,565.0 Cr 1.8% -3.7% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹101,163.0 Cr 4.5% 1.8% -10% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

5.5%

-0.9%

2.1%

SENSEX

0.7%

-3.9%

-8.9%


You may also like the below Video Courses